LINC00707

Across TCGA pan-cancer cohorts, LINC00707 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated LINC00707 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC00707 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00707 expression acts as an unfavorable survival marker, although some lineages such as SKCM and ESCA show a favorable association.

LUAD, HNSC, and LGG are the cancer types where LINC00707 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.475	0.726	<.001	62	view →
HNSC	OS	Median	All	0.620	0.745	.002	51	view →
LGG	OS	Median	All	0.372	0.521	<.001	50	view →
SKCM	OS	Median	All	0.415	0.276	.003	43	view →
ESCA	OS	Tertile	III,IV	0.739	0.386	.002	41	view →
KIRP	DFS	Quartile	All	0.809	0.986	<.001	34	view →
LUSC	OS	Quartile	II,III,IV	0.531	0.716	.010	32	view →
UCS	DFS	Tertile	IV	0.996	0.426	.017	30	view →
PAAD	DFS	Tertile	All	0.372	0.589	<.001	30	view →
MESO	OS	Median	IV	0.838	0.313	.001	27	view →
STAD	OS	Quartile	III,IV	0.284	0.624	.009	24	view →
UCEC	DFS	Quartile	All	0.838	0.913	.002	22	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

LINC00707–LUAD (OS)

Open the LUAD breakdown →